Major Pharmaceuticals 2026-07-29 Health serious FDA
Health · FDA · Recall #FDA-D-0700-2026
Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose… Recall
Issued July 29, 2026 · Major Pharmaceuticals
In July 2026, Major Pharmaceuticals recalled the Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose…, a serious health recall reported by the FDA.
Compiled by Dana Whitfield, RecallCheckr
What this means for you
Subpotent Drug
What you should do
- 1 Stop using Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Major Pharmaceuticals to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Major Pharmaceuticals
- Category
- Health
- Recall date
- July 29, 2026
- Units affected
- Not reported
- Sold at
- Nationwide in the USA.
- Recall number
- FDA-D-0700-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Major Pharmaceuticals has 6 recalls in our database.
- We're tracking 3,689 Health recalls in our database.
- This is the 469th Health recall we've logged in 2026.